Mar 30, 2021   SOURCE: BusinessWire

Outlook on the Fill Finish Manufacturing Global Market to 2027 - by Product, End-user and Geography - ResearchAndMarkets.com

The "Fill Finish Manufacturing Market Forecast to 2027 - COVID-19 Impact and Analysis - by Product and End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the global fill finish manufacturing market is expected to reach US$ 12,547.23 million by 2027 from US$ 6,129.03 million in 2019. The market is estimated to grow at a CAGR of 9.6 % from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Based on products, the fill finish manufacturing market is segmented into consumables and instruments. The consumables is further segmented into prefilled syringes, vials, cartridges, and other consumables. In 2019, the consumables segment accounted for a larger share of the market and is expected to register a higher CAGR during the forecast period. Growth of this segment is attributed to high replacement rate compared with that of instruments, rising adoption of prefilled syringes, wide applications of vials in lyophilization, and increasing fill-finish outsourcing.

Based on end user, the fill finish manufacturing market is segmented into contract manufacturing organizations, biopharmaceutical companies, and other end users. The contract manufacturing organizations segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period.

COVID-19 pandemic has become the most significant challenge across the world. However, the pandemic has brought several growth opportunities to the pharmaceutical and biopharmaceutical companies to strengthen their R&D for vaccine formulation against the coronavirus. Moderna, Inc. and Catalent, Inc. announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna's mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent's biologics facility in Bloomington.

On December 9, 2020, CureVac N.V, a global clinical-stage biopharmaceutical company developed a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Fareva announced an agreement regarding the fill & finish manufacturing of CureVac's COVID-19 vaccine candidate, CVnCoV, at Fareva's Pau and Val-de-Reuil-sites in France. Wockhardt Ltd has entered into an agreement with the UK government to fill and finish COVID-19 vaccine vials at its subsidiary CP Pharmaceuticals' facility based in Wrexham, North Wales. Thus, such collaborations are expected to show a positive impact on the fill-finish manufacturing market in the coming few years.

Becton, Dickinson and Company (BD), West Pharmaceutical Services, Gerresheimer, Robert Bosch (Syntegon Technology GmbH), IMA, Optima, Bausch + Strobel, Groninger, Maquinaria Industrial Dara, NIPRO PharmPackaging, SCHOTT AG, SGD Pharma, and Stevanato Group are among the leading companies operating in the fill finish manufacturing market.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Fill Finish Manufacturing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Fill Finish Manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Market Dynamics

Drivers

  • Rising Adoption of Prefilled Syringes for Parenteral Administration
  • Elevating Demand for Biologics

Restraints

  • Growing Competition in Biopharmaceutical Contract Manufacturing Industry

Opportunities

  • Low Business Costs in Emerging Markets

Future Trends

  • Single-Use Systems for Aseptic Fill Finish

Companies Mentioned

  • Becton, Dickinson and Company (BD)
  • West Pharmaceutical Services
  • Gerresheimer
  • Robert Bosch (Syntegon Technology Gmbh)
  • Ima
  • Optima
  • Bausch + Strobel
  • Groninger
  • Maquinaria Industrial Dara
  • Nipro Pharmpackaging
  • Schott AG
  • Sgd Pharma
  • Stevanato Group

For more information about this report visit https://www.researchandmarkets.com/r/bk6mz8